Literature DB >> 3749523

Conservative treatment of breast cancer in Europe: report of the Groupe Européen de Curiethérapie.

B Pierquin, J J Mazeron, D Glaubiger.   

Abstract

These two meetings organised successively to discuss the conservative methods of treatment of breast cancer, made it possible to gather data on a substantial number of patients from an important number of European centers. It is encouraging to note that there is a general consensus among the various European centers concerning the basic principles of treatment and that long years of experience have led to the use of well defined technical protocols which are relatively similar from one center to another. Since serious complications have now become exceptional, we foresee that the conservative treatment of breast cancer will continue to evolve on a technical level as the indications for this approach continue to develop within the overall plan of patient care with the assurance that optimum results may be maintained. However, we must point out that the lack of a unified system of reporting irradiation doses in volumes corresponding to the possible and/or real extension of the tumor remains an obstacle in developing a truly unified attitude in the application of these techniques. Each center defines the radiation dose given by wide field techniques and the dose given by cone-down (boost) techniques in a relatively arbitrary way without true anatomic correlations. These correlations must be found and defined, so that a specified dose has a universal meaning. The role of the surgeon in the successful application of breast conserving techniques is far from negligible. Now that our colleagues who wield the scalpel have begun to gain confidence in the curative powers of irradiation, we may hope that a close collaboration between radiotherapist and surgeon will lead to the application of conservative techniques under optimal conditions in the breast, with the development of minimal tumorectomy and minimal curative cone-down dose; and in the axilla, with the development of axillary dissection limited to the lower border of the pectoralis minor and followed by radiation therapy only if more than two nodes show tumor involvement. However, it is important to point out that while it is possible to use radiation therapy alone to treat breast cancer and conserve the breast at all stages of the development of the disease, it is not possible to use conservative surgical techniques alone as a substitute for adequate irradiation. The development of protocols which routinely apply breast conserving methods in synonymous with the development and routine use of the best radiation therapy techniques. This article presents two separate and complementary studies of two different sets of data presented at two successive meetings.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3749523     DOI: 10.1016/s0167-8140(86)80153-0

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  Preliminary Results of Quadrantectomy and Radiation Therapy for Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

Review 2.  The significance of a supraclavicular node metastasis in patients with breast cancer. A literature review.

Authors:  J M Debois
Journal:  Strahlenther Onkol       Date:  1997-01       Impact factor: 3.621

3.  Management of axillary lymph nodes in breast cancer: a national patterns of care study of 17,151 patients.

Authors:  D R Brenin; M Morrow; J Moughan; J B Owen; J F Wilson; D P Winchester
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

Review 4.  [Is axillary dissection in clinically lymph node-negative breast carcinoma further indicated?].

Authors:  F K Böhler; H Eiter; W Rhomberg
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

5.  [Diagnostic Value of CYFRA 21-1 Measurement in Fine-Needle Aspiration Washouts for Detection of Axillary Recurrence in Postoperative Breast Cancer Patients].

Authors:  So Yeon Won; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon; Vivian Youngjean Park; Min Jung Kim
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-01-31

6.  Regional radiotherapy versus an axillary lymph node dissection after lumpectomy: a safe alternative for an axillary lymph node dissection in a clinically uninvolved axilla in breast cancer. A case control study with 10 years follow up.

Authors:  Patty H Spruit; Sabine Siesling; Marloes A G Elferink; Ernest J A Vonk; Carel J M Hoekstra
Journal:  Radiat Oncol       Date:  2007-10-30       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.